搜索临床试验以:PD-1抑制剂
总计7211个结果
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
OncoC4, Inc.Avance Clinical; OncoC4 AU Pty Ltd招聘中黑色素瘤 | 肾细胞癌 | 宫颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 食道癌 | 输卵管癌 | 非小细胞肺癌 | 胆管癌 | 膀胱癌 | 子宫内膜癌 | 头颈部鳞状细胞癌 | 肛门癌 | 原发性腹膜癌 | 卵巢高级别浆液性腺癌 | 胃食管结合部癌澳大利亚
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.未知
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated To Inner Mongolia...招聘中
-
Shanghai Cell Therapy Research Institute未知
-
Northwestern UniversityNational Cancer Institute (NCI)招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Shanghai Cell Therapy Research Institute未知
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical University主动,不招人
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Peking University First HospitalYiZhou International Cancer Hospital未知肿瘤转移 | 免疫疗法 | 质子治疗
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern Medical University 和其他合作者招聘中
-
Peking University Cancer Hospital & InstituteInnovent Biologics (Suzhou) Co. Ltd.完全的
-
Shanghai Zhongshan Hospital尚未招聘